Saylor, P. J., Keating, N. L., Freedland, S. J., & Smith, M. R. (2011). Gonadotropin releasing hormone (GnRH) agonists and the risks of diabetes and cardiovascular disease in men with prostate cancer.
Citação norma ChicagoSaylor, Philip J., Nancy L. Keating, Stephen J. Freedland, and Matthew R. Smith. Gonadotropin Releasing Hormone (GnRH) Agonists and the Risks of Diabetes and Cardiovascular Disease in Men With Prostate Cancer. 2011.
Deismireacht MLASaylor, Philip J., Nancy L. Keating, Stephen J. Freedland, and Matthew R. Smith. Gonadotropin Releasing Hormone (GnRH) Agonists and the Risks of Diabetes and Cardiovascular Disease in Men With Prostate Cancer. 2011.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.